OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
Norimitsu Hariguchi(Otsuka (Japan)), Makoto Matsumoto(Tottori University Hospital), Shunpei Ishikawa(The University of Tokyo), Ryuki Kitamoto(Otsuka (Japan)), Yoshio Ohba(Otsuka (Japan)), Motohiro Itotani(Otsuka (Japan)), Yohei Hayashi(Otsuka (Japan)), Xiuhao Chen(Otsuka (Japan)), Yukitaka Uematsu(Otsuka (Japan)), Toshio Shinohara(Otsuka (Japan)), Miki Matsuba(Otsuka (Japan)), Izuru Nakamura(Otsuka (Japan)), Hiroshi Shimizu(The University of Osaka), Mamoru Fujiwara(Otsuka (Japan)), Yoshikazu Kawano(Otsuka (Japan)), Yoshikazu Haraguchi(Otsuka (Japan)), Isao Takemura(Otsuka (Japan))
Cited by 130
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k